Search research articles
Contact Us
Filters
Showing results (231-240 of 299) with videos related to
Page
of 30
Sort By:
Investigational New Drugs
|
August 7, 2019
Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma
Shahneen Sandhu, Catriona M McNeil, Patricia LoRusso, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 2010
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
E Claire Dees, Jeffrey R Infante, Roger B Cohen, et al.
Investigational New Drugs
|
August 22, 2014
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma
Nizar M Tannir, Andres Forero-Torres, Radhakrishnan Ramchandren, et al.
International Journal of Nanomedicine
|
February 25, 2015
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
Huali Wu, Jeffrey R Infante, Vicki L Keedy, et al.
British Journal of Clinical Pharmacology
|
December 16, 2017
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours
Noelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2013
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours
Jeffrey R Infante, Kyriakos P Papadopoulos, Johanna C Bendell, et al.
Revista Espanola De Medicina Nuclear
|
December 18, 2009
[Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation]
J Serrano Vicente, J R Infante de la Torre, M L Domínguez Grande, et al.
Biomed Research International
|
August 23, 2014
Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment
Anne Kultti, Chunmei Zhao, Netai C Singha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2021
A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors
James J Harding, Melinda Telli, Pamela Munster, et al.
Investigational New Drugs
|
September 4, 2015
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
Suzanne F Jones, Lillian L Siu, Johanna C Bendell, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 299) with videos related to
Sort By:
Page
of 30
Investigational New Drugs
|
August 7, 2019
Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma
Shahneen Sandhu, Catriona M McNeil, Patricia LoRusso, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 2010
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
E Claire Dees, Jeffrey R Infante, Roger B Cohen, et al.
Investigational New Drugs
|
August 22, 2014
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma
Nizar M Tannir, Andres Forero-Torres, Radhakrishnan Ramchandren, et al.
International Journal of Nanomedicine
|
February 25, 2015
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
Huali Wu, Jeffrey R Infante, Vicki L Keedy, et al.
British Journal of Clinical Pharmacology
|
December 16, 2017
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours
Noelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2013
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours
Jeffrey R Infante, Kyriakos P Papadopoulos, Johanna C Bendell, et al.
Revista Espanola De Medicina Nuclear
|
December 18, 2009
[Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation]
J Serrano Vicente, J R Infante de la Torre, M L Domínguez Grande, et al.
Biomed Research International
|
August 23, 2014
Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment
Anne Kultti, Chunmei Zhao, Netai C Singha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2021
A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors
James J Harding, Melinda Telli, Pamela Munster, et al.
Investigational New Drugs
|
September 4, 2015
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
Suzanne F Jones, Lillian L Siu, Johanna C Bendell, et al.
Page
of 30